Literature DB >> 1603805

Domain flexibility in aspartic proteinases.

A Sali1, B Veerapandian, J B Cooper, D S Moss, T Hofmann, T L Blundell.   

Abstract

Comparison of the three-dimensional structures of native endothiapepsin (EC 3.4.23.6) and 15 endothiapepsin oligopeptide inhibitor complexes defined at high resolution by X-ray crystallography shows that endothiapepsin exists in two forms differing in the relative orientation of a domain comprising residues 190-302. There are relatively few interactions between the two parts of the enzyme; consequently, they can move as separate rigid bodies. A translational, librational, and screw analysis of the thermal parameters of endothiapepsin also supports a model in which the two parts can move relative to each other. In the comparison of different aspartic proteinases, the rms values are reduced by up to 47% when the two parts of the structure are superposed independently. This justifies description of the differences, including those between pepsinogen and pepsin (EC 3.4.34.1), as a rigid movement of one part relative to another although considerable distortions within the domains also occur. The consequence of the rigid body movement is a change in the shape of the active site cleft that is largest around the S3 pocket. This is associated with a different position and conformation of the inhibitors that are bound to the two endothiapepsin forms. The relevance of these observations to a model of the hydrolysis by aspartic proteinases is briefly discussed.

Mesh:

Substances:

Year:  1992        PMID: 1603805     DOI: 10.1002/prot.340120209

Source DB:  PubMed          Journal:  Proteins        ISSN: 0887-3585


  18 in total

Review 1.  Structural aspects of activation pathways of aspartic protease zymogens and viral 3C protease precursors.

Authors:  A R Khan; N Khazanovich-Bernstein; E M Bergmann; M N James
Journal:  Proc Natl Acad Sci U S A       Date:  1999-09-28       Impact factor: 11.205

Review 2.  Multiple diverse ligands binding at a single protein site: a matter of pre-existing populations.

Authors:  Buyong Ma; Maxim Shatsky; Haim J Wolfson; Ruth Nussinov
Journal:  Protein Sci       Date:  2002-02       Impact factor: 6.725

3.  Molecular-dynamics investigation of molecular flexibility in ligand binding.

Authors:  B Mao
Journal:  Biochem J       Date:  1992-11-15       Impact factor: 3.857

4.  Statistical coupling analysis of aspartic proteinases based on crystal structures of the Trichoderma reesei enzyme and its complex with pepstatin A.

Authors:  Alessandro S Nascimento; Sandra Krauchenco; Alexander M Golubev; Alla Gustchina; Alexander Wlodawer; Igor Polikarpov
Journal:  J Mol Biol       Date:  2008-07-22       Impact factor: 5.469

Review 5.  Prediction of binding constants of protein ligands: a fast method for the prioritization of hits obtained from de novo design or 3D database search programs.

Authors:  H J Böhm
Journal:  J Comput Aided Mol Des       Date:  1998-07       Impact factor: 3.686

6.  Penicillopepsin-JT2, a recombinant enzyme from Penicillium janthinellum and the contribution of a hydrogen bond in subsite S3 to k(cat).

Authors:  Q N Cao; M Stubbs; K Q Ngo; M Ward; A Cunningham; E F Pai; G C Tu; T Hofmann
Journal:  Protein Sci       Date:  2000-05       Impact factor: 6.725

7.  An automatic method involving cluster analysis of secondary structures for the identification of domains in proteins.

Authors:  R Sowdhamini; T L Blundell
Journal:  Protein Sci       Date:  1995-03       Impact factor: 6.725

8.  A structural comparison of 21 inhibitor complexes of the aspartic proteinase from Endothia parasitica.

Authors:  D Bailey; J B Cooper
Journal:  Protein Sci       Date:  1994-11       Impact factor: 6.725

9.  Crystal structures of the histo-aspartic protease (HAP) from Plasmodium falciparum.

Authors:  Prasenjit Bhaumik; Huogen Xiao; Charity L Parr; Yoshiaki Kiso; Alla Gustchina; Rickey Y Yada; Alexander Wlodawer
Journal:  J Mol Biol       Date:  2009-03-11       Impact factor: 5.469

10.  Structure of a secreted aspartic protease from C. albicans complexed with a potent inhibitor: implications for the design of antifungal agents.

Authors:  C Abad-Zapatero; R Goldman; S W Muchmore; C Hutchins; K Stewart; J Navaza; C D Payne; T L Ray
Journal:  Protein Sci       Date:  1996-04       Impact factor: 6.725

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.